Canopy Biosciences LLC has acquired Core Diagnostics, a provider of biomarker analysis services for biopharmaceutical researchers. No financial terms were disclosed. Canopy Biosciences is backed by ...
Zacks Investment Research on MSN
Core Laboratories stock's stability makes it a wise hold for now
Over the past six months, Core Laboratories Inc. CLB has shown remarkable growth, outpacing both the Oil & Gas Field Services ...
Core Laboratories is the premier provider of reservoir characterization services. Its foundational core analysis business has been virtually untouched over the last several decades, and the firm has ...
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) announced better-than-expected revenue in Q3 CY2025, but sales fell by 3.7% year on year to $699.9 million. The company expects the full year’s ...
Diagnostic chain Metropolis Healthcare on Monday said it will acquire Core Diagnostics for Rs 247 crore. The company's board has approved the acquisition of 100 per cent stake in Core Diagnostics from ...
On Jan 18, we issued an updated research report on Quest Diagnostics, Inc.DGX. The stock carries a Zacks Rank #3 (Hold). We are optimistic about Quest Diagnostics' consistent efforts to refocus on ...
The Global Core Clinical Molecular Diagnostics Market is valued at approximately USD 5.26 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 9.5% over the forecast ...
ST. LOUIS, Dec. 4, 2019 /PRNewswire/ -- Canopy Biosciences, LLC announced today the acquisition of Core Diagnostics, a leading CLIA-certified provider of biomarker analysis services for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback